Clinical Trials Browser

Phase 2 × Solid Tumor × camrelizumab × Clear all

NCT04346381 2023-09-18

Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor

Phase 2 Completed

Other solid neoplasm

Solid Tumor

NCT04832204 2021-04-05

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Phase 2 Unknown

Other solid neoplasm

Solid Tumor